INGN logo

INOGEN INC

INGNNASDAQ
🏆 #3898 by market capEarnings Nov 3 · PostUS Equity
$5.36▼ $0.09 (−1.65%)
Market closed · at close
🔔
Track INGN
Get earnings, price moves & breaking news on Telegram
Track
24h▼ 1.6%
7d▲ 5.3%
14d▲ 4.6%
30d▼ 0.2%
ytd▼ 20.1%
1y▼ 34.4%
🏦Market Cap
$145M
Small Cap
📈Revenue Growth (YoY)
+3.1%
Slowing
📊Gross Margin
44.5%
Healthy
💵FCF Margin
0.3%
Thin
⚖️P/S Ratio
0.4x
Cheap
Otter Score
64
Fair

Trading Snapshot

Day Range
$5.31 – $5.41
52-Week Range
$5.05 – $9.13
Volume
$3.84B
Avg Volume
$2.68B
Shares Outstanding
27.1M
Next Earnings
Nov 1, 2026

Fundamentals Snapshot

Annual Revenue
$349M
Last Q Revenue
$95M
P/E Ratio
—
P/S Ratio
0.4x
EPS (TTM)
$-0.90
Dividend Yield
—
Dilution (1yr)
+14.9%

Why Investors Own INGN

  • ✓High-growth profile — revenue up +25.5% YoY with expanding US Equity exposure.
  • ✓Healthy economics — 73% gross margin and 6% free-cash-flow margin.
  • ✓New products and segments could unlock additional revenue streams.
⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

INGN logo

INOGEN INC

INGN
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$349M▲ +3.9% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
47.6%▲ +3.2% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
−$30M▼ −29.0% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
−$22M▲ +93.2% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
27.2M▲ +14.9% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
$86M▼ −$8M YoY
StockOtter · stockotter.space

About INOGEN INC

Inogen, Inc. operates as a medical technology enterprise dedicated to designing, fabricating, and distributing oxygen concentration equipment. These cutting-edge devices are engineered to provide continuous oxygen support for patients managing persistent respiratory conditions. The company's diverse product range features the popular portable Inogen One, which efficiently draws oxygen from the surrounding atmosphere to offer an independent supply, alongside stationary Inogen At Home concentrators, Tidal Assist Ventilators, and various associated accessories. Inogen serves a broad clientele, including individual patients, medical professionals, and insurance providers, both domestically in the United States and globally. Furthermore, the company facilitates direct equipment rentals to patients. Founded in 2001, Inogen, Inc. is headquartered in Goleta, California.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)
💎Quality★★★★★
🚀Growth★★★★★
⚖️Valuation★★★★★
⚡Momentum★★★★★
💧Dilution★★★★★
Overall Score
Fair
64/100

Analyst Price Target

ⓘ
Average Target
$6.23
▲ +16.2% Upside
High Target$7.52
Low Target$5.79
Based on 13 analysts

Latest News & Updates

🚀
MarketWatch·2h ago

INOGEN INC tops quarterly estimates as demand accelerates

Revenue grew double digits with management guiding above consensus; margins continued to expand.

🛰️
CNBC·5h ago

Analysts lift INGN price targets on improving margins

Several firms raised targets, citing stronger free cash flow and a healthier backlog.

🌌
Reuters·1d ago

INOGEN INC announces new agreement to expand its footprint

The move broadens the company’s reach and could add incremental revenue over the next year.